Embody Review
Flexible, medically guided compounded GLP-1 weight loss with transparent monthly pricing.
Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology
Quick Verdict
Flexible, medically guided compounded GLP-1 weight loss with transparent monthly pricing.
Who it's for: Embody is the easy first-time pick for compounded GLP-1: clear pricing, single category focus, and no upsells into adjacent services. If you've tried two or three programs and want something that just does the GLP-1 piece well without complexity, Embody is a strong candidate. Less suited to anyone who wants brand-name Ozempic or Wegovy, or who needs TRT, ED, or hair loss support alongside weight loss.
Bottom line: Honest, simple, and focused. No brand-name GLP-1 access is the main trade-off, but for cost-conscious first-time users who just want a guided compounded GLP-1 program without upsells or complexity, that trade-off is rational. Transparent monthly pricing with no hidden fees is a genuine differentiator in a category where pricing opacity is common.
- No hidden fees and no dose surcharges
- Pure GLP-1 focus — no upsells into other categories
- Reasonable entry price for a guided program
- Transparent pricing disclosed before intake completion
- Compounded only, no brand-name GLP-1 access
- Single-category. won't help with adjacent goals
Pros & Cons In Detail
Embody Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Embody.
| Program / Membership Fee | Included in monthly plan |
| Medication Cost (From) | From $149 – $349/mo |
Transparent monthly pricing that bundles compounded GLP-1 medication, provider oversight, and shipping into a single fee. No separate membership charge, no dose surcharges, and no long-term contracts. Pricing is disclosed upfront before you complete intake.
Who Embody Is For
Embody is the easy first-time pick for compounded GLP-1: clear pricing, single category focus, and no upsells into adjacent services. If you've tried two or three programs and want something that just does the GLP-1 piece well without complexity, Embody is a strong candidate. Less suited to anyone who wants brand-name Ozempic or Wegovy, or who needs TRT, ED, or hair loss support alongside weight loss.
First-time GLP-1 users who want a simple, no-frills compounded plan.
Signature Programs
- ›Compounded semaglutide
- ›Compounded tirzepatide
- ›Provider-led titration
Medication Formulary
The Bottom Line
Honest, simple, and focused. No brand-name GLP-1 access is the main trade-off, but for cost-conscious first-time users who just want a guided compounded GLP-1 program without upsells or complexity, that trade-off is rational. Transparent monthly pricing with no hidden fees is a genuine differentiator in a category where pricing opacity is common.
With an editor score of 4.4 / 5 across cost, experience, and trust, Embody is one of the strong mid-tier options in the glp-1 weight loss category we cover.
See how Embody compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
- FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
- FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.